Watz Henrik, Waschki Benjamin, Boehme Corinna, Claussen Martin, Meyer Thorsten, Magnussen Helgo
Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, D-22927 Grosshansdorf, Germany.
Am J Respir Crit Care Med. 2008 Apr 1;177(7):743-51. doi: 10.1164/rccm.200707-1011OC. Epub 2007 Nov 29.
Physical activity is reduced in patients with chronic obstructive pulmonary disease (COPD). COPD has a systemic component that includes significant extrapulmonary effects that may contribute to its severity in individual patients.
To investigate the association of extrapulmonary effects of the disease and its comorbidities with reduced physical activity in patients with COPD.
In a cross-sectional study, 170 outpatients with COPD (GOLD [Global Initiative for Chronic Obstructive Lung Disease] stages I-IV; BODE [body mass index, airway obstruction, dyspnea, and exercise capacity] score 0-10) underwent a series of tests. Physical activity was assessed over 5 to 6 consecutive days by using a multisensor accelerometer armband that records steps per day and the physical activity level (total daily energy expenditure divided by whole-night sleeping energy expenditure). Cardiovascular status was assessed by echocardiography, vascular Doppler sonography, and levels of N-terminal pro-B-type natriuretic peptide. Mental status, metabolic/muscular status, systemic inflammation, and anemia were assessed by Beck Depression Inventory, bioelectrical impedance analysis, handgrip strength, high-sensitivity C-reactive protein/fibrinogen, and hemoglobin, respectively.
In a multivariate linear regression analysis using either steps per day or physical activity level as a dependent variable, the extrapulmonary parameters that were associated with reduced physical activity in patients with COPD independently of GOLD stages or BODE score were N-terminal pro-B-type natriuretic peptide levels, echocardiographically measured left ventricular diastolic function, and systemic inflammation.
Higher values of systemic inflammation and left cardiac dysfunction are associated with reduced physical activity in patients with COPD.
慢性阻塞性肺疾病(COPD)患者的体力活动减少。COPD具有全身系统性成分,包括显著的肺外效应,这可能导致个体患者病情严重程度增加。
研究该疾病的肺外效应及其合并症与COPD患者体力活动减少之间的关联。
在一项横断面研究中,170例COPD门诊患者(全球慢性阻塞性肺疾病倡议组织[GOLD]分级I-IV级;体重指数、气道阻塞、呼吸困难和运动能力[BODE]评分0-10)接受了一系列检查。使用多传感器加速计臂带连续5至6天评估体力活动,该臂带记录每日步数和体力活动水平(每日总能量消耗除以整夜睡眠能量消耗)。通过超声心动图、血管多普勒超声和N末端B型利钠肽前体水平评估心血管状态。分别通过贝克抑郁量表、生物电阻抗分析、握力、高敏C反应蛋白/纤维蛋白原和血红蛋白评估精神状态、代谢/肌肉状态、全身炎症和贫血情况。
在以每日步数或体力活动水平作为因变量的多变量线性回归分析中,与COPD患者体力活动减少独立相关且不受GOLD分级或BODE评分影响的肺外参数为N末端B型利钠肽前体水平、超声心动图测量的左心室舒张功能和全身炎症。
全身炎症水平升高和左心功能障碍与COPD患者体力活动减少有关。